Drug Tariff entry

Currently waiting for a response from Department of Health and Social Care, they should respond promptly and normally no later than (details).

Dear Department of Health and Social Care,

The remit of the Drug Tariff is to use competition to encourage lower prices and create an incentive for pharmacy contractors to procure in a manner that is cost- effective for the NHS. The decision for inclusion being made by the Secretary of State. This being the case how is it possible that an identical product to another (minor differences in excipients only) is not included in the drug tariff despite being £84 cheaper than the alternative brand. The specific product included in the Drug Tariff is Aceteff (acetylcysteine 600mg) 30 tablets (Dunelm) £89.50 Part VIIIA (C), the alternative Nacsys (acetylcysteine 600mg) 30 tablets (Atlantic Pharma) £5.50 is not included in the drug tariff.
The tax payer has therefore being paying over £84 more for a generic prescription for over 12 months with the pharmacist potentially making a significant profit if dispensing Nacsys against this prescription. This is unacceptable given the cost pressures on the NHS.
What is the process for determining inclusion of products in the Drug Tariff?
Is there a process (and what is it) to identify where cheaper identical products are available to ensure these are included in the tariff as a priority?

Yours faithfully,

Mr Vijay Singh

Dear Department of Health and Social Care,

I have now updated my contact details as requested.

Yours faithfully,

Vijay Singh

Looking for an EU Authority?

You can request documents directly from EU Institutions at our sister site AskTheEU.org . Find out more .

AskTheEU.org